Noun: pylarify (piflufolastat f 18) injection dose QTY: 192 each
Ended Awarded
- Contract number
- 36C25025N0816
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $692,874
Award facts
- Contract value 100% obligated
- $692,874.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc. The contract is for the supply of 192 units of PYLARIFY (piflufolastat F-18) injection, a radiopharmaceutical used in positron emission tomography (PET) scans to detect and image prostate cancer. The contract has a ceiling value of $692,874.24 and a period of performance through June 30, 2026.
This award is part of a larger indefinite delivery vehicle, likely a Blanket Purchase Agreement or Indefinite Delivery Contract, that Lantheus Holdings maintains under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with the VA. These contract vehicles enable the VA and other federal healthcare providers, such as the Defense Health Agency and NIH Clinical Center, to efficiently procure critical radiopharmaceuticals and medical imaging products to support their medical imaging programs across military treatment facilities, VA medical centers, and other government healthcare facilities.
Quick answers
Who was awarded contract 36C25025N0816?
36C25025N0816 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on July 1, 2025.
How much is contract 36C25025N0816 worth?
The government has obligated $692,874 on 36C25025N0816.
Is contract 36C25025N0816 an order under another contract?
Yes. 36C25025N0816 is a delivery order under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25025N0816 competed?
The extent of competition for 36C25025N0816 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award